Trials / Unknown
UnknownNCT03604016
Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver
Pilot Study to Assess the Antiviral Activity and Safety of Besifovir Dipivoxil 150mg and L-carnitine 660mg Compared to Tenofovir Alafenamide 25mg in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 76 (estimated)
- Sponsor
- IlDong Pharmaceutical Co Ltd · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Pilot study to assess the antiviral activity and safety of Besifovir dipivoxil 150mg and L-carnitine 660mg compared to Tenofovir Alafenamide 25mg in chronic hepatitis B patients with Nonalcoholic fatty liver
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Besifovir dipivoxil | Besifovir dipivoxil 150 mg |
| DRUG | L-carnitine | Besifovir dipivoxil 150 mg |
| DRUG | Tenofovir Alafenamide | Tenofovir Alafenamide 25mg |
Timeline
- Start date
- 2018-09-23
- Primary completion
- 2020-07-30
- Completion
- 2020-07-30
- First posted
- 2018-07-27
- Last updated
- 2018-08-23
Source: ClinicalTrials.gov record NCT03604016. Inclusion in this directory is not an endorsement.